Literature DB >> 29573958

Beta 2-Microglobulin and the Severity of Coronary Stenosis in Patients With Acute Coronary Syndrome.

Chenglong Zhang1, Fengjuan Li2, Tianyi Long2, Fei Li2, Liming Peng2, Ke Xia2, Ran Jing2, Qiying Xie2, Tianlun Yang2.   

Abstract

BACKGROUND: Previous studies have shown that beta 2-microglobulin (B2M) could predict all-cause mortality and cardiovascular mortality in various groups of people. However, the relationship between B2M and severity of coronary stenosis in patients with acute coronary syndrome has not been established.
METHODS: We enrolled 872 consecutive patients admitted with acute coronary syndrome in our study. All participants underwent coronary angiography examination or stent implantation after admission. The severity of coronary stenosis was assessed by Gensini score and the presentation of triple-vessel disease. B2M and other biochemical parameters were measured. All subjects were divided into quartiles of B2M. Multivariate linear regression and logistic regression were applied in the analysis.
RESULTS: Gensini score and the prevalence of triple-vessel disease were elevated in accordance with increasing B2M quartiles (p=0.002 and p<0.001, respectively). Multivariate regression showed diabetes (p=0.031), high-sensitivity C-reactive protein (hs-CRP, p=0.043) and B2M (p=0.006) were positively correlated with Gensini score. Logistic regression analysis revealed that the crude and fully adjusted odds ratios of triple-vessel disease were 2.34 (95% CI: 1.58-3.46) and 1.97 (95% CI: 1.14-3.40) in the fourth quartile of B2M compared with the first quartile, respectively. However, no interactive relationships were found in subgroup analysis by estimated glomerular filtration rate or hs-CRP in the above associations, neither in the distribution of Gensini score (p for interaction>0.05 for both).
CONCLUSION: Our data indicated that B2M was an independent risk factor of coronary stenosis in patients with acute coronary syndrome.
Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Beta 2-microglobulin; Coronary angiography; Gensini score; Triple-vessel disease.

Mesh:

Substances:

Year:  2018        PMID: 29573958     DOI: 10.1016/j.hlc.2018.02.016

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  4 in total

1.  Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population.

Authors:  Yangxi Huang; Yufeng Lin; Xiaobing Zhai; Long Cheng
Journal:  Front Cardiovasc Med       Date:  2022-05-13

2.  A New Score for Determining Thrombus Burden in STEMI Patients: The MAPH Score.

Authors:  Ozge Ozcan Abacioglu; Arafat Yildirim; Mine Karadeniz; Serkan Abacioglu; Nermin Yildiz Koyunsever; Ferhat Dindas; Mustafa Dogdus; Mustafa Kaplangoray
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome.

Authors:  Sisi Bi; Yue Zhao; Qingling Peng; Wenxue Liu; Guogang Zhang; Chenglong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

4.  Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome.

Authors:  Tianyi Long; Liming Peng; Fei Li; Ke Xia; Ran Jing; Xiangwei Liu; Qiying Xie; Tianlun Yang; Chenglong Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.